Met Life Investment Management, LLC Magenta Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$6.03 - $15.24 $61,819 - $156,240	-10,252 Closed	0 $0
Q4 2019 Jul 12, 2023	BUY	$9.07 - $15.84 $92,985 - $162,391	10,252 New	10,252 $155,000
Q3 2019 Jul 12, 2023	BUY	$9.63 - $14.0 $98,726 - $143,528	10,252 New	10,252 $105,000
Q3 2019 Mar 22, 2023	BUY	$9.63 - $14.0 $98,726 - $143,528	10,252 New	10,252 $105,000
Q3 2019 Nov 14, 2019	BUY	$9.63 - $14.0 $98,726 - $143,528	10,252 New	10,252 $105,000
Q2 2019 Jul 12, 2023	BUY	$13.4 - $17.67 $137,376 - $181,152	10,252 New	10,252 $151 Million

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.